Renal failure

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
mTOR inhibitor 1 substance
Phase II: 1 Phase IV: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Guard Therapeutics International AB (publ) Commercial
    RMC-035
    2024-510658-28-00 3 countries 2024 n=124
    Ended

Phase IV

1 trial
  • Hospices Civils De Lyon Academic
    EVEROLIMUS
    2024-513814-37-00 1 country 2020 n=20
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Guard Therapeutics International AB (publ) Commercial 1 Phase II 0
Hospices Civils De Lyon Academic 1 Phase IV 1
New trials by year
2020
1
2024
1
← All indication landscapes